Aastrom Biosciences, Inc. (ASTM) Tops Q3 EPS by 14c

Aastrom Biosciences, Inc. (NASDAQ: ASTM) reported Q3 EPS of ($0.52), $0.14 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $9.66 million versus the consensus estimate of $6.73 million.

For earnings history and earnings-related data on Aastrom Biosciences, Inc. (ASTM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• CoStar Group acquires Zonda for $800M, adding new home data